2017 annual financial data

XORTX Therapeutics 2017 Operating cash flow margin

Direct answer

Operating cash flow margin was Not calculable.

Operating income was -427,107 CAD and net income was -474,201 CAD.
Operating cash flow was 91,174 CAD.

Get free XORTX Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 CAD
Operating income
-427,107 CAD
Net income
-474,201 CAD
Operating cash flow
91,174 CAD